| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $313.8M | +13.6% | +19.5% |
| Cost of Revenue | $59.3M | +7.7% | +22.0% |
| Gross Profit | $254.5M | +15.1% | +18.9% |
| R&D Expense | $42.2M | +5.9% | +5.5% |
| SG&A Expense | $38.7M | -9.0% | +10.2% |
| Operating Income | $19.8M | +58.3% | +45.2% |
| Pre-tax Income | $27.0M | +79.0% | +78.9% |
| Income Tax | $9.2M | +2397.8% | +126.2% |
| Net Income | $17.8M | +20.7% | +61.3% |
| EPS (Basic) | $0.40 | +21.2% | +60.0% |
| EPS (Diluted) | $0.40 | +21.2% | +66.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.03B | -3.5% | +321.4% |
| Accounts Receivable | $361.8M | +54.1% | +33.3% |
| Current Assets | $1.45B | +6.8% | +150.6% |
| Total Assets | $2.04B | +6.3% | +99.1% |
| Current Liabilities | $616.6M | +15.2% | +20.5% |
| Stockholders' Equity | $216.7M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $112.5M | — | — |
| Capital Expenditures | $7.2M | — | — |
| Investing Cash Flow | -$5.1M | — | — |
| Financing Cash Flow | $597.1M | — | — |
| Free Cash Flow | $105.3M | — | — |
| -24.7% |